BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34687375)

  • 1. Autophagy machinery in glioblastoma: The prospect of cell death crosstalk and drug resistance with bioinformatics analysis.
    Qin Y; Xiong S; Ren J; Sethi G
    Cancer Lett; 2024 Jan; 580():216482. PubMed ID: 37977349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular stress responses as modulators of drug cytotoxicity in pharmacotherapy of glioblastoma.
    Kusaczuk M; Ambel ET; Naumowicz M; Velasco G
    Biochim Biophys Acta Rev Cancer; 2024 Jan; 1879(1):189054. PubMed ID: 38103622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DCvax: A promising advancement in oncology for the treatment of glioblastoma.
    Fareed A; Rohail S; Adnan A; Khan AM
    Rare Tumors; 2023; 15():20363613231179541. PubMed ID: 37256198
    [No Abstract]   [Full Text] [Related]  

  • 4. Epigallocatechin-3-Gallate and Genistein for Decreasing Gut Dysbiosis, Inhibiting Inflammasomes, and Aiding Autophagy in Alzheimer's Disease.
    Muraleedharan A; Ray SK
    Brain Sci; 2024 Jan; 14(1):. PubMed ID: 38275516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteostasis and neurodegeneration: a closer look at autophagy in Alzheimer's disease.
    Barmaki H; Nourazarian A; Khaki-Khatibi F
    Front Aging Neurosci; 2023; 15():1281338. PubMed ID: 38020769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autophagy Modulation and Its Implications on Glioblastoma Treatment.
    Chen J; Rodriguez AS; Morales MA; Fang X
    Curr Issues Mol Biol; 2023 Oct; 45(11):8687-8703. PubMed ID: 37998723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rising impact of cell death research.
    Nowak-Sliwinska P; Griffioen AW
    Apoptosis; 2023 Dec; 28(11-12):1503-1504. PubMed ID: 37751104
    [No Abstract]   [Full Text] [Related]  

  • 8. Advanced Bioinformatics Analysis and Genetic Technologies for Targeting Autophagy in Glioblastoma Multiforme.
    Manea AJ; Ray SK
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editorial: Molecular and immune influences in the progression of gliomas.
    Malik K; Mian N; Caffo M; Zhao H
    Front Oncol; 2023; 13():1102445. PubMed ID: 36816949
    [No Abstract]   [Full Text] [Related]  

  • 10. Intersections of Ubiquitin-Proteosome System and Autophagy in Promoting Growth of Glioblastoma Multiforme: Challenges and Opportunities.
    Visintin R; Ray SK
    Cells; 2022 Dec; 11(24):. PubMed ID: 36552827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Programmed cell death lives.
    Griffioen AW; Nowak-Sliwinska P
    Apoptosis; 2022 Oct; 27(9-10):619-621. PubMed ID: 35943678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unconventional Protein Secretion in Brain Tumors Biology: Enlightening the Mechanisms for Tumor Survival and Progression.
    Iglesia RP; Prado MB; Alves RN; Escobar MIM; Fernandes CFL; Fortes ACDS; Souza MCDS; Boccacino JM; Cangiano G; Soares SR; de Araújo JPA; Tiek DM; Goenka A; Song X; Keady JR; Hu B; Cheng SY; Lopes MH
    Front Cell Dev Biol; 2022; 10():907423. PubMed ID: 35784465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of autophagy as a therapeutic option in glioblastoma.
    Manea AJ; Ray SK
    Apoptosis; 2021 Dec; 26(11-12):574-599. PubMed ID: 34687375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Interplay between Senescence, Apoptosis and Autophagy in Glioblastoma Multiforme-Role in Pathogenesis and Therapeutic Perspective.
    Pawlowska E; Szczepanska J; Szatkowska M; Blasiak J
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29562589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are There Thresholds in Glioblastoma Cell Death Responses Triggered by Temozolomide?
    He Y; Kaina B
    Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30925722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Momelotinib sensitizes glioblastoma cells to temozolomide by enhancement of autophagy via JAK2/STAT3 inhibition.
    Liu T; Li A; Xu Y; Xin Y
    Oncol Rep; 2019 Mar; 41(3):1883-1892. PubMed ID: 30664175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic Suppression of Glioblastoma Cell Growth by Combined Application of Temozolomide and Dopamine D2 Receptor Antagonists.
    Liu Z; Jiang X; Gao L; Liu X; Li J; Huang X; Zeng T
    World Neurosurg; 2019 Aug; 128():e468-e477. PubMed ID: 31048057
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.